News & Filings
ERIS \u2014 Recent Activity
3 items in the last 14 days
Eris Lifesciences Ltd (NSE:ERIS) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
Discover how Eris Lifesciences Ltd (NSE:ERIS) navigates robust growth in branded formulations and international markets while addressing margin pressures and strategic brand realignments.
Click to open →
Eris Lifesciences Ltd (NSE:ERIS) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Eris Lifesciences Ltd (NSE:ERIS) reports robust financial performance with a 10% revenue growth and strategic collaborations, despite facing some operational challenges.
Click to open →
Eris Lifesciences Ltd (NSE:ERIS) Q4 2025 Earnings Call Highlights: Robust Revenue Growth Amidst ...
Despite impressive revenue and EBITDA growth, Eris Lifesciences Ltd (NSE:ERIS) navigates product shortages and strategic hurdles.
Click to open →
Get alerts for important filings
Add ERIS to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.